News
More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...
2d
Zacks Investment Research on MSNNovo Nordisk Rises 6% So Far in August: How to Play the Stock
Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...
Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that obesity is a problem at all.
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Combining liraglutide with a very low-calorie ketogenic diet can lead to greater weight loss than the diet alone in adults ...
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Here's how to stay in a deficit safely. If you’re trying to lose weight, it’s natural to want an efficient solution. During ...
Obesity is a worldwide problem that is increasing. It also is associated with ocular problems. A recent study found that in ...
17h
Everyday Health on MSNFDA Raises Safety Concerns About Compounded GLP-1 Weight Loss Drugs
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
TOP LOBBYIST: MOAA earned a spot on this prestigious list for the 18th straight year. Weight loss drugs will no longer be covered for TRICARE For Life (TFL) beneficiaries as of Aug. 31 – a policy ...
SHREVEPORT, La. - A new drug developed by Eli Lily works in a unique way compared to treatments already on the market, like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results